| 000 | 01447 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516084547.0 | ||
| 264 | 0 | _c20120726 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1347-5215 | ||
| 024 | 7 |
_a10.1248/bpb.35.617 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKitano, Toru | |
| 245 | 0 | 0 |
_aVitamin K3 analogs induce selective tumor cytotoxicity in neuroblastoma. _h[electronic resource] |
| 260 |
_bBiological & pharmaceutical bulletin _c2012 |
||
| 300 |
_a617-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aCaveolin 1 |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aCell Survival |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 | _aGene Expression Profiling |
| 650 | 0 | 4 | _aHeme Oxygenase-1 |
| 650 | 0 | 4 | _aHuman Umbilical Vein Endothelial Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeuroblastoma _xdrug therapy |
| 650 | 0 | 4 | _aProteome |
| 650 | 0 | 4 |
_aVitamin K 3 _xanalogs & derivatives |
| 700 | 1 | _aYoda, Hiroyuki | |
| 700 | 1 | _aTabata, Keiichi | |
| 700 | 1 | _aMiura, Motofumi | |
| 700 | 1 | _aToriyama, Masaharu | |
| 700 | 1 | _aMotohashi, Shigeyasu | |
| 700 | 1 | _aSuzuki, Takashi | |
| 773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 35 _gno. 4 _gp. 617-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.35.617 _zAvailable from publisher's website |
| 999 |
_c21669196 _d21669196 |
||